Skip to main content
. 2022 Jan 18;66(1):e01397-21. doi: 10.1128/AAC.01397-21

TABLE 3.

Activity of KBP-7072 and tetracycline class comparators against Gram-negative clinical isolates

Antimicrobial agent (no. of isolates) MIC50 (mg/liter) MIC90 (mg/liter) MIC range (mg/liter) CLSIa
%S %I %R
Enterobacterales (410)
  KBP-7072 0.25 2 0.06–16
  Doxycycline 2 32 0.5 to >32 67.6 5.6 26.8
  Minocycline 2 16 0.25 to >32 79.0 6.1 14.9
  Omadacycline 2 16 0.5 to >32
  Tetracycline 2 >64 0.5 to >64 64.4 3.2 32.4
  Tigecycline 0.5 2 0.12–8 93.4b 5.6 1.0
Enterobacterales (133)c tetracycline resistant
  KBP-7072 1 4 0.12–16
  Doxycycline 32 >32 4 to >32 3.0 15.0 82.0
  Minocycline 8 >32 1 to >32 38.3 15.8 45.9
  Omadacycline 4 32 0.5 to >32
  Tetracycline >64 >64 16 to >64 0.0 0.0 100
  Tigecycline 1 4 0.12–8 79.7 17.3 3.0
Citrobacter freundii species complex (22)
  KBP-7072 0.25 0.5 0.12–1
  Doxycycline 2 8 1–32 86.4 4.5 9.1
  Minocycline 1 8 0.5–16 86.4 9.1 4.5
  Omadacycline 1 4 1–8
  Tetracycline 1 8 0.5 to >64 86.4 4.5 9.1
  Tigecycline 0.25 1 0.12–2 100.0b 0.0 0.0
C. koseri (21)
  KBP-7072 0.12 0.25 0.12–0.5
  Doxycycline 1 2 0.5–4 100.0 0.0 0.0
  Minocycline 0.5 2 0.5–4 100.0 0.0 0.0
  Omadacycline 1 1 0.5–2
  Tetracycline 1 2 1–4 100.0 0.0 0.0
  Tigecycline 0.25 0.25 0.12–0.5 100.0b 0.0 0.0
Enterobacter cloacae species complex (50)
  KBP-7072 0.25 0.5 0.25–4
  Doxycycline 2 2 1–16 92.0 0.0 8.0
  Minocycline 2 4 0.5–32 96.0 0.0 4.0
  Omadacycline 2 4 1–16 94.0b,d 2.0 4.0
  Tetracycline 2 4 1 to >64 90.0 0.0 10.0
  Tigecycline 0.5 0.5 0.25–4 96.0b 4.0 0.0
E. cloacae species complex (18) ceftazidime-nonsusceptible (MIC, ≥8 mg/liter)
  KBP-7072 0.25 0.5 0.25–4
  Doxycycline 2 4 1–16 94.4 0.0 5.6
  Minocycline 2 4 0.5–32 94.4 0.0 5.6
  Omadacycline 2 4 1–16 94.4b,d 0.0 5.6
  Tetracycline 2 16 1 to >64 88.9 0.0 11.1
  Tigecycline 0.5 0.5 0.25–4 94.4b 5.6 0.0
Escherichia coli (77)
  KBP-7072 0.12 0.5 0.06–2
  Doxycycline 2 32 0.5 to >32 58.4 14.3 27.3
  Minocycline 1 8 0.5–32 84.4 7.8 7.8
  Omadacycline 1 2 0.5–16
  Tetracycline 2 >64 0.5 to >64 57.1 0.0 42.9
  Tigecycline 0.25 0.5 0.12–4 98.7b 1.3 0.0
E. coli (26) ESBL phenotype
  KBP-7072 0.25 1 0.12–2
  Doxycycline 8 32 1–32 38.5 26.9 34.6
  Minocycline 2 8 0.5–32 84.6 7.7 7.7
  Omadacycline 2 4 0.5–16
  Tetracycline >64 >64 1 to >64 38.5 0.0 61.5
  Tigecycline 0.25 1 0.12–4 96.2b 3.8 0.0
Klebsiella aerogenes (21)
  KBP-7072 0.25 0.5 0.25–4
  Doxycycline 2 4 0.5 to >32 90.5 0.0 9.5
  Minocycline 2 2 1 to >32 95.2 0.0 4.8
  Omadacycline 2 2 1–32
  Tetracycline 2 8 1 to >64 85.7 4.8 9.5
  Tigecycline 0.5 0.5 0.25–8 95.2b 0.0 4.8
K. oxytoca (53)
  KBP-7072 0.25 0.5 0.12–2
  Doxycycline 1 8 0.5–32 88.7 3.8 7.5
  Minocycline 1 4 0.25–16 94.3 1.9 3.8
  Omadacycline 1 2 0.5–16
  Tetracycline 1 8 0.5 to >64 88.7 1.9 9.4
  Tigecycline 0.25 1 0.12–2 100.0b 0.0 0.0
K. pneumoniae (80)
  KBP-7072 0.25 1 0.12–4
  Doxycycline 1 16 0.5 to >32 71.2 3.8 25.0
  Minocycline 2 8 0.5 to >32 83.8 7.5 8.8
  Omadacycline 2 8 0.5–32 87.5b,d,e 7.5 5.0
  Tetracycline 2 >64 0.5 to >64 72.5 0.0 27.5
  Tigecycline 0.5 1 0.25–4 96.2b 3.8 0.0
K. pneumoniae (27) ESBL phenotype
  KBP-7072 0.5 2 0.25–4
  Doxycycline 8 32 1 to >32 40.7 11.1 48.1
  Minocycline 4 >32 1 to >32 74.1 7.4 18.5
  Omadacycline 4 16 1–32 81.5b,d,e 7.4 11.1
  Tetracycline >64 >64 1 to >64 40.7 0.0 59.3
  Tigecycline 0.5 2 0.25–4 92.6b 7.4 0.0
Morganella morganii (20)
  KBP-7072 1 2 0.5–8
  Doxycycline 32 >32 1 to >32 45.0 0.0 55.0
  Minocycline 4 32 1 to >32 50.0 5.0 45.0
  Omadacycline 8 8 2 to >32
  Tetracycline 32 >64 1 to >64 45.0 0.0 55.0
  Tigecycline 1 2 0.5–4 95.0b 5.0 0.0
Proteus mirabilis (22)
  KBP-7072 4 8 1–16
  Doxycycline 32 >32 16 to >32 0.0 0.0 100.0
  Minocycline 16 32 8 to >32 0.0 13.6 86.4
  Omadacycline 16 >32 8 to >32
  Tetracycline 32 64 32–64 0.0 0.0 100.0
  Tigecycline 4 4 1–8 31.8b 59.1 9.1
Providencia spp. (22)f
  KBP-7072 4 4 0.5–8
  Doxycycline >32 >32 2 to >32 4.5 4.5 90.9
  Minocycline 16 >32 2 to >32 18.2 22.7 59.1
  Omadacycline 32 32 4 to >32
  Tetracycline 64 >64 2 to >64 9.1 0.0 90.9
  Tigecycline 2 4 0.5–4 86.4b 13.6 0.0
Serratia marcescens (22)
  KBP-7072 0.5 1 0.5–16
  Doxycycline 4 16 2–32 59.1 22.7 18.2
  Minocycline 2 4 2–32 90.9 4.5 4.5
  Omadacycline 4 8 2 to >32
  Tetracycline 8 >64 4 to >64 4.5 45.5 50.0
  Tigecycline 1 2 0.5–8 95.5b 0.0 4.5
Acinetobacter baumannii-calcoaceticus species complex (22)
  KBP-7072 0.5 1 0.03–1
  Doxycycline 1 >32 0.06 to >32 63.6 9.1 27.3
  Minocycline 0.5 8 0.03–16 72.7 18.2 9.1
  Omadacycline 2 8 0.12–8
  Tetracycline 16 >64 1 to >64 40.9 4.5 54.5
  Tigecycline 2 4 0.12–4
A. baumannii-calcoaceticus species complex (13) carbapenem resistant
  KBP-7072 0.5 1 0.25–1
  Doxycycline 8 >32 0.25 to >32 38.5 15.3 46.2
  Minocycline 4 16 0.25–16 53.8 30.8 15.4
  Omadacycline 4 8 2–8
  Tetracycline 64 >64 4 to >64 7.7 0.0 92.3
  Tigecycline 4 4 2–4
Pseudomonas aeruginosa (22)
  KBP-7072 8 16 0.5 to >32
  Doxycycline 16 32 4 to >32
  Minocycline 16 32 4 to >32
  Omadacycline 32 >32 2 to >32
  Tetracycline 16 32 4 to >64
  Tigecycline 8 16 0.5 to >16
Stenotrophomonas maltophilia (22)
  KBP-7072 0.5 1 0.25–8
  Doxycycline 2 4 1–16
  Minocycline 0.5 1 0.25–8 95.5 4.5 0.0
  Omadacycline 4 8 2–32
  Tetracycline 32 64 16–64
  Tigecycline 1 2 0.5–16
Haemophilus influenzae (52)
  KBP-7072 0.12 0.25 0.06–0.5
  Doxycycline 0.5 0.5 0.12–1
  Minocycline 0.25 0.5 0.12–0.5
  Omadacycline 0.5 1 0.25–2 100.0b,e 0.0 0.0
  Tetracycline 0.5 0.5 0.25–8 98.1 0.0 1.9
  Tigecycline 0.25 0.25 0.06–0.5 94.2
H. parainfluenzae (12)
  KBP-7072 0.25 0.5 0.06–0.5
  Doxycycline 0.5 2 0.25–16
  Minocycline 1 2 0.25–4
  Omadacycline 1 2 0.25–2 100.0b,e 0.0 0.0
  Tetracycline 0.5 1 0.25–32 91.7 0.0 8.3
  Tigecycline 0.5 0.5 0.06–1
Moraxella catarrhalis (21)
  KBP-7072 0.06 0.06 ≤0.015 to 0.06
  Doxycycline 0.12 0.12 0.06–0.25
  Minocycline 0.06 0.06 0.03–0.06
  Omadacycline 0.12 0.25 0.06–0.25
  Tetracycline 0.25 0.5 0.12–0.5 100.0 0.0 0.0
  Tigecycline 0.06 0.06 0.03–0.06
a

Criteria as published by CLSI (22).

b

FDA breakpoints.

c

Organisms include Citrobacter freundii species complex (2), E. cloacae species complex (5), E. coli (33), K. aerogenes (2), K. oxytoca (5), K. pneumoniae (22), M. morganii (11), P. mirabilis (22), P. rettgeri (11), P. stuartii (9), and S. marcescens (11).

d

Using ABSSSI breakpoints.

e

Using CABP breakpoints.

f

Organisms include Providencia alcalifaciens (1), P. rettgeri (12), and P. stuartii (9).